Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. 1) The severity of the condition can vary widely.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway.”

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing. A review of the current literature.” And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

NOVEMBER 18, 2022

In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.

Edibles 86

Edibles Hemp Epilepsy Programs 86

Medicinal Marijuana Association

FEBRUARY 10, 2024

Implement research findings by consulting experts and translating data into practical actions. Research methodologies in cannabis studies can vary from observational studies that simply observe and report data, to randomized controlled trials that provide more robust evidence.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 16, 2022

Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. One of the most interesting aspects of the keto-canna connection is the overlap in conditions that may benefit from either cannabinoids, the ketogenic diet or both. It has been used since the 1920’s for treating refractory epilepsy and is still employed regularly today. Other conditions.

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Cannabis Law Report

JULY 25, 2022

Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. You must make sure that your condition qualifies and go through the application process. .

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the truth was that many of the early medical cannabis patients were severely ill.

Policy 96

Policy Research and Development Conditions Consumption 96

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. Psilocybin therapy is a breakthrough avenue for providing people with treatment for these ailments.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? While research is ongoing, existing studies and anecdotal evidence show that medical cannabis is useful for a variety of conditions, both physical and psychiatric.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Consequently, the scientific community was astounded to discover that the ground-grown plant may offer relief from widespread medical conditions , including: AIDS. Amyotrophic lateral sclerosis (ALS). Chronic pain.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Expanded Qualifying Conditions. Of the issues with Texas’ Compassionate Use Program, perhaps the most significant is its short list of qualifying conditions. More Telemedicine.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Cheri

APRIL 1, 2022

In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy. Not everyone encounters this annoying condition, but many people starting a keto diet do. As always, more research and more data is needed to know for sure. Read more here.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Veriheal

FEBRUARY 10, 2022

Data and storage options via the integrated Microsoft Azure platform. The DOH maintains the right to add other medical conditions to the following list of eligible conditions for medical cannabis in South Dakota: AIDS/HIV. Epilepsy and seizures. Amyotrophic lateral sclerosis (ALS). Multiple sclerosis. Crohn’s disease.

Programs 52

Programs Chronic Pain Patients Conditions 52

CannaTech

SEPTEMBER 16, 2018

These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

APRIL 4, 2019

Further there is a growing body of evidence that various forms of cannabis could help in the treatment of epilepsy and seizures, post-traumatic stress disorder (PTSD), glaucoma, dementia, Alzheimers, autism, fibromyalgia and a range of auto-immune diseases.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

MAY 10, 2019

To answer this question in short, Yes, CBD is legal, but under certain conditions. People suffering from pain, or conditions that can only be treated with Cannabidiol, vaping oil proves to be the best in that case giving instant relief. There is a lack of safety data availability. CBD is all relaxation without intoxication.

Vaping 45

Vaping Oil CBD Epilepsy 45

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Around 90% of participants self-medicated with cannabis daily. Participants were followed-up at baseline, 4, 8 and 12?months.

Patients 49

Patients Marijuana Epilepsy Treatment 49